Carlos Peris Torres

201720182019202020212022202320243 4 1 9 27 15 22 8

Public access

5 articles

1 article

available

not available

Based on funding mandates

Juan Carlos Rodriguez-ManzanequePrincipal Investigator, GENYOVerified email at genyo.es
Silvia Redondo GarcíaAntibody and Vaccine Group, Centre for Cancer Immunology, University of SouthamptonVerified email at soton.ac.uk
Javier Rodríguez BaenaPostdoctoral at Instituto de Neurociencias de AlicanteVerified email at umh.es
Orlando Serrano GarridoUniversidad de PanamáVerified email at up.ac.pa
Pedro Carmona-SáezUniversity of Granada & GENyO. (ORCID: 0000-0002-6173-7255)Verified email at ugr.es
Raúl López-DomínguezPhD student, GENYOVerified email at genyo.es
Rubén Fernández-Rodríguez (ORCID:...Icahn School of Medicine at Mount SinaiVerified email at mssm.edu
Jose L Fernandez-LunaHead, Genetics Unit. Valdecilla University Hospital. Santander, SpainVerified email at scsalud.es

Carlos Peris Torres

GENYO

Verified email at genyo.es - Homepage


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response FJ Rodríguez-Baena, S Redondo-García, C Peris-Torres, ... Scientific reports 8 (1), 13103, 2018	25	2018
Extracellular protease ADAMTS1 is required at early stages of human uveal melanoma development by inducing stemness and endothelial-like features on tumor cells C Peris-Torres, MC Plaza-Calonge, R López-Domínguez, ... Cancers 12 (4), 801, 2020	20	2020
Stroma-derived but not tumor ADAMTS1 is a main driver of tumor growth and metastasis R Fernández-Rodríguez, FJ Rodríguez-Baena, E Martino-Echarri, ... Oncotarget 7 (23), 34507, 2016	18	2016
ADAMTS proteases and the tumor immune microenvironment: Lessons from substrates and pathologies S Redondo-García, C Peris-Torres, R Caracuel-Peramos, ... Matrix biology plus 9, 100054, 2021	14	2021
ADAMTS1 supports endothelial plasticity of glioblastoma cells with relevance for glioma progression O Serrano-Garrido, C Peris-Torres, S Redondo-García, HG Asenjo, ... Biomolecules 11 (1), 44, 2021	8	2021
Inhibition of ADAMTS1 expression by lentiviral CRISPR/Cas9 gene editing technology C Peris-Torres, O Serrano, MC Plaza-Calonge, ... ADAMTS Proteases: Methods and Protocols, 13-24, 2020	5	2020
ADAMTS proteases and uveal melanoma: unveiling the contribution of ADAMTS1 to the plasticity of tumor cells C Peris Torres Universidad de Granada, 2021		2021

The system can't perform the operation now. Try again later.

Articles 1–7

Citations per year